InvestorsHub Logo
Followers 898
Posts 148975
Boards Moderated 0
Alias Born 08/13/2010

Re: makinbacon1 post# 1054

Friday, 09/24/2021 4:14:41 PM

Friday, September 24, 2021 4:14:41 PM

Post# of 1166
$CEMI The FDA has granted emergency use authorization to Chembio Diagnostics Inc's
CEMI partner LumiraDx's COVID-19 antibody test.
LumiraDx and Chembio had announced a partnership on March 12, 2020 to develop point of care COVID-19 antibody test.
The nod comes for LumiraDx SARS-CoV-2 Ab Test, a microfluidic immunofluorescence assay for the qualitative detection of total antibodies in whole human blood, plasma, or serum for indication of recent or prior infection.
Recently, the $CEMI received a $28 million order to supply DPP SARS-CoV-2 Antigen tests for delivery during 2021 in Brazil.


Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CEMI News